| Oct 7 |
AstraZeneca looks to boost cardiovascular pipeline with $2B license deal
|
| Oct 7 |
AstraZeneca and Gilead Sciences merger would be the biggest in the pharma history
|
| Oct 4 |
Pharma Stock Roundup: FDA Approves SNY's Dupixent for COPD & More
|
| Oct 4 |
AbbVie Cuts 2024 Earnings Guidance to Include Acquisition Costs
|
| Oct 4 |
Thermo Fisher plant making Astra/ Sanofi RSV drug reportedly breached FDA rules
|
| Oct 4 |
How to minimise a capital gains tax impact on your investments
|
| Oct 3 |
AstraZeneca Seeks Expanded Use For Blood Cancer Drug Calquence, FDA Grants Priority Review
|
| Oct 3 |
AstraZeneca's Calquence sNDA Gets FDA Priority Tag for Expanded Use
|
| Oct 3 |
AstraZeneca supplemental NDA for Calquence accepted by FDA
|
| Oct 3 |
U.S. tweaks 2025 Medicare price negotiation process
|
